Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the firm, Marketbeat.com reports. Five investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokers that have issued a report on the stock in the last year is $22.00.

A number of research analysts recently issued reports on the stock. Citizens Jmp raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Scotiabank upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research report on Monday, March 2nd. Weiss Ratings raised shares of Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Wednesday, March 18th. Wells Fargo & Company lifted their price target on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock an “overweight” rating in a report on Thursday, March 26th. Finally, Cantor Fitzgerald boosted their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 17th.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Principal Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 21.6% in the fourth quarter. Principal Financial Group Inc. now owns 24,953,351 shares of the real estate investment trust’s stock worth $472,617,000 after acquiring an additional 4,431,897 shares during the period. Lasalle Investment Management Securities LLC acquired a new stake in Sabra Healthcare REIT during the 4th quarter valued at approximately $66,938,000. Engineers Gate Manager LP raised its holdings in Sabra Healthcare REIT by 3,190.3% during the 2nd quarter. Engineers Gate Manager LP now owns 3,179,303 shares of the real estate investment trust’s stock worth $58,626,000 after purchasing an additional 3,082,677 shares during the last quarter. Norges Bank bought a new position in Sabra Healthcare REIT during the 4th quarter worth approximately $57,945,000. Finally, Sumitomo Mitsui Trust Group Inc. lifted its position in shares of Sabra Healthcare REIT by 1,019.8% in the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,005,374 shares of the real estate investment trust’s stock worth $56,922,000 after purchasing an additional 2,736,993 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Trading Up 1.9%

Shares of SBRA stock opened at $19.86 on Friday. Sabra Healthcare REIT has a twelve month low of $15.75 and a twelve month high of $21.07. The stock’s fifty day simple moving average is $19.82 and its 200 day simple moving average is $19.09. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $5.01 billion, a P/E ratio of 31.03, a P/E/G ratio of 1.55 and a beta of 0.67.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. Sabra Healthcare REIT’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.20 annualized dividend and a yield of 6.0%. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.